|
|||||||||||||||
|
||||||||||||||||||
Data:2009-12-12 2:34
Source: Hong Kong and Macao Information Author: Xu Bo
Ma Ying-lung (600,993): a unique product formulations, and has independent intellectual property rights, so a higher gross margin products, corporate profits, a larger space. Meanwhile, the company's products are mostly of Chinese herbs, enjoy the state's encouragement of the relevant preferential policies of enterprise products from the increased competitiveness in the market and profits the ability to further increase.
At present, the company's business model began to change in the direction of chain pharmacies, pharmacy chains by virtue of the advantages of a unified product distribution, the future tends to be more optimistic about the potential for development. The secondary market, the stock hit a new intraday high today, rising afternoon larger space, the proposed bargain-hunting investors concerned about the midline.
